Pismo debuts in the Global Fintech Fest 2024
Global tech specialists to discussmodernisation trends and present local clients BANGALORE,India,Aug. 28,2024-- Pismo,the global cloud-native API-based platform,joins the Global Fintech Fest (GFF) for
life
The 50th JINHAN FAIR: Your Gateway to 2024's Top Home & Gift Trends
GUANGZHOU,China,Aug. 28,2024-- The 50thJinhan Fair for Home & Gifts (JINHAN FAIR) is set to take place from October 21st to 27th,2024,at Pazhou,Guangzhou,China. This trade show is your gateway to
Shilpa Medicare Makes History: First Indian Company Completes Phase 1 Trial for Recombinant Human Albumin (rHA) 20%
RAICHUR,India,Aug. 28,2024-- In a major breakthrough,Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship
ATRenew Inc. Reports Unaudited Second Quarter 2024 Financial Results
SHANGHAI,Aug. 20,2024-- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE),a leading technology-driven pre-owned consumer electronics transactions and services platform in Chin
GLOBUS EVENTS ENLARGES ITS PET PORTFOLIO BY INVESTING IN CHINA PET EXPO
SHANGHAI,Aug. 21,2024-- GLOBUS EVENTS,the organizer of Pet Fair Asia – Asia\'s leading international pet show –has reached an agreement with Beijing Lanneret International Exhibitions (a local Beiji
TOYO Co., Ltd Announces First Half 2024 Unaudited Financial Results
TOKYO,Aug. 21,2024-- TOYO Co.,Ltd(Nasdaq: TOYO) ("TOYO" or the "Company"),a solar solution company,today announced its financial results for the six months ended June 30,2024.
Full Truck Alliance Co. Ltd. Announces Second Quarter 2024 Unaudited Financial Results
GUIYANG,China,Aug. 21,2024-- Full Truck Alliance Co. Ltd. ("FTA" or the"Company") (NYSE: YMM),a leading digital freight platform,today announced its unaudited financial results for
UTime Limited Announces Ambitious AI Health Strategy and Strategic Collaboration
SHENZHEN,China,Aug. 21,2024-- UTime Limited (NASDAQ: WTO) ("UTime" or the "Company") is pleased to announce its ambitious strategy for advancing AI-driven health solutions. Recogni
China's First Approved KRAS G12C Inhibitor: Innovent Announces the Approval of Dupert® (Fulzerasib) by the National Medical Products Administration of China
SAN FRANCISCOand SUZHOU,China,Aug. 22,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high qua
Unlock the Power of Direct Investment: How BAI Capital's Direct Approach Transforms the EB-5 Experience
HO CHI MINH CITY,Vietnam,Aug. 22,2024-- BAI Capital,a distinguished boutique real estate developer based in Miami,Florida,is expanding its footprint into Vietnam,significantly impacting the EB-5 marke